stockrowSotera Health Company
SHC Healthcare Diagnostics & Research
Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.
- Revenue
- +4.36%
- EPS
- +20.1%
- Free cash flow
- +65.0%
- Total debt
- +0.14%
Quarter to September 2026, against a year earlier
Follow SHC
Alert me
Sotera Health Company (SHC) Free cash flow
Sotera Health Company's free cash flow for fiscal 2025 was $149.2M, up 230.8% from $45.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was $135.4M. Over the past ten years it has ranged from −$362.7M (fiscal 2023) to $179.4M (fiscal 2021); the current reading is higher than 88% of that period. Sotera Health Company ranks 17th of 49 Diagnostics & Research companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $149.2M | 230.81% |
| FY2024 | $45.1M | — |
| FY2023 | −$362.7M | — |
| FY2022 | $95.6M | (46.72%) |
| FY2021 | $179.4M | 167.42% |
| FY2020 | $67.1M | (26.92%) |
| FY2019 | $91.8M | 95.49% |
| FY2018 | $47.0M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $57.7M | 37.26% |
| Jun 2026 | $42.0M | — |
| Mar 2026 | −$16.7M | — |
| Dec 2025 | $52.4M | 49.81% |
| 25 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| QGEN QIAGEN N.V. compare | $440.6M |
| VCYT Veracyte, Inc. compare | $161.9M |
| SHC Sotera Health Company | $135.4M |
| RDNT RadNet, Inc. compare | $74.4M |
| CDNA CareDx, Inc. compare | $59.8M |
| BLLN BillionToOne, Inc. compare | $33.9M |
| ADPT Adaptive Biotechnologies Corporation compare | −$8.8M |
| NEO NeoGenomics, Inc. compare | −$26.5M |
| GRAL GRAIL, Inc. compare | −$312.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on SHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement